Our Services
Medical Information
Helpful Resources
Published on: 9/13/2026
Yes, it is relatively common for sertraline (Zoloft) to feel less effective over time, a pattern clinicians sometimes call antidepressant tolerance, tachyphylaxis, or "Prozac poop-out," affecting an estimated 25% or more of people on long-term SSRIs. Other explanations can look identical, including new life stress, worsening or shifting diagnosis (such as bipolar depression), poor sleep, thyroid or vitamin deficiencies, alcohol use, missed doses, drug interactions, or a change in pill manufacturer. Options often include a dose adjustment, switching medications, adding an augmenting agent, or combining medication with therapy, and stopping abruptly can trigger discontinuation symptoms, so several factors matter here. See below to understand the important details before deciding what to do next.
If your medication seems to have stopped helping, a free, instant, online symptom check can help you organize what you are experiencing, flag patterns worth mentioning to your prescriber, and point you toward the right next step instead of waiting months to find out whether this is tolerance or something else entirely.
Last reviewed for medical accuracy: 09/12/2026
Is it normal for sertraline to stop working after months or years?
It can be unsettling to feel that sertraline—a well-established SSRI (selective serotonin reuptake inhibitor) you’ve been taking for depression or anxiety—isn’t helping like it once did. Clinicians sometimes call this “SSRI tachyphylaxis” or “poop-out,” but the phenomenon isn’t fully understood. Here’s what we know, based on credible guidelines and clinical studies, and what you can do if it happens to you.
Tolerance development
Changing life stressors
Pharmacokinetic changes
Unrecognized comorbidities
Lifestyle factors
Watch for:
If these emerge months to years after starting sertraline, it’s worth assessing whether it’s true tachyphylaxis or another issue.
Keep a symptom diary
Review your full health picture
Consider dosage adjustment
Augmentation strategies
Switching antidepressants
Non-pharmacological therapies
Monitor for safety
If you’re unsure whether your latest symptoms signal true sertraline tolerance, a new condition or a side effect, you might consider a free, online symptom check, using the doctor approved Ubie Symptom Checker. Try the Ubie Symptom Checker to gather more insight before your next appointment.
Always consult your healthcare provider before making changes to sertraline or any medication. If you experience life-threatening or serious symptoms, seek emergency care immediately.
Key takeaways
(References)
* Rapport DJ, Calabrese JR. Tolerance to fluoxetine. J Clin Psychopharmacol. 1993 Oct;13(5):361. doi: 10.1097/00004714-199310000-00011. PMID: 8227494.
* Wald A. Irritable Bowel Syndrome. Curr Treat Options Gastroenterol. 1999 Feb;2(1):13-19. doi: 10.1007/s11938-999-0013-6. PMID: 11096567.
* Sepede G, De Berardis D, Gambi F, Campanella D, La Rovere R, D'Amico M, Cicconetti A, Penna L, Peca S, Carano A, Mancini E, Salerno RM, Ferro FM. Olanzapine augmentation in treatment-resistant panic disorder: a 12-week, fixed-dose, open-label trial. J Clin Psychopharmacol. 2006 Feb;26(1):45-9. doi: 10.1097/01.jcp.0000195108.01898.17. PMID: 16415705.
* Skarphedinsson G, Weidle B, Ivarsson T. Sertraline Treatment of Nonresponders to Extended Cognitive-Behavior Therapy in Pediatric Obsessive-Compulsive Disorder. J Child Adolesc Psychopharmacol. 2015 Sep;25(7):574-9. doi: 10.1089/cap.2015.0041. Epub 2015 Sep 8. PMID: 26348088; PMCID: PMC4576946.
* Woroń J, Siwek M, Gorostowicz A. Adverse effects of interactions between antidepressants and medications used in treatment of cardiovascular disorders. Psychiatr Pol. 2019 Oct 30;53(5):977-995. doi: 10.12740/PP/OnlineFirst/96286. Epub 2019 Oct 30. PMID: 31955180.
* Wallace K, Uchitel J, Prange L, Jasien J, Bonner M, D'Alli R, Maslow G, Mikati MA. Characterization of Severe and Extreme Behavioral Problems in Patients With Alternating Hemiplegia of Childhood. Pediatr Neurol. 2020 Oct;111:5-12. doi: 10.1016/j.pediatrneurol.2020.06.012. Epub 2020 Jun 27. PMID: 32951661.
* Pu B, Wang N, Wang C, Sun B. Clinical observation on the benefits of antidepressant intervention in advanced cancer patients. Medicine (Baltimore). 2022 Jul 1;101(26):e29771. doi: 10.1097/MD.0000000000029771. Epub 2022 Jul 1. PMID: 35776994; PMCID: PMC9239637.
* Rao Y, Yang R, Zhao J, Cao Q. Efficacy and tolerability of antidepressant drugs in treatment of depression in children and adolescents: a network meta-analysis. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2022 Aug 1;51(4):480-490. doi: 10.3724/zdxbyxb-2022-0145. PMID: 37202104; PMCID: PMC10264982.
* Krzystanek M, Martyniak E, Pałasz A, Skałacka K, Chwalba A, Wierzbiński P. Amantadine in Treatment of Dysthymia-The Pilot Case Series Study. Pharmaceuticals (Basel). 2023 Jun 19;16(6). doi: 10.3390/ph16060897. Epub 2023 Jun 19. PMID: 37375844; PMCID: PMC10301632.
* Günther A, Burmester A, Fabri M, Tittelbach J, Wiegand C. Co-Treatment with Ritonavir or Sertraline Enhances Itraconazole Efficacy Against Azole-Resistant Trichophyton indotineae Isolates. J Fungi (Basel). 2025 Sep 25;11(10). doi: 10.3390/jof11100698. Epub 2025 Sep 25. PMID: 41149888; PMCID: PMC12564935.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.